Matthiesen Stina, Diederichsen Søren Zöga, Hansen Mikkel Klitzing Hartmann, Villumsen Christina, Lassen Mats Christian Højbjerg, Jacobsen Peter Karl, Risum Niels, Winkel Bo Gregers, Philbert Berit T, Svendsen Jesper Hastrup, Andersen Tariq Osman
Department of Computer Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Vital Beats, Copenhagen, Denmark.
JMIR Hum Factors. 2021 Nov 26;8(4):e26964. doi: 10.2196/26964.
Artificial intelligence (AI), such as machine learning (ML), shows great promise for improving clinical decision-making in cardiac diseases by outperforming statistical-based models. However, few AI-based tools have been implemented in cardiology clinics because of the sociotechnical challenges during transitioning from algorithm development to real-world implementation.
This study explored how an ML-based tool for predicting ventricular tachycardia and ventricular fibrillation (VT/VF) could support clinical decision-making in the remote monitoring of patients with an implantable cardioverter defibrillator (ICD).
Seven experienced electrophysiologists participated in a near-live feasibility and qualitative study, which included walkthroughs of 5 blinded retrospective patient cases, use of the prediction tool, and questionnaires and interview questions. All sessions were video recorded, and sessions evaluating the prediction tool were transcribed verbatim. Data were analyzed through an inductive qualitative approach based on grounded theory.
The prediction tool was found to have potential for supporting decision-making in ICD remote monitoring by providing reassurance, increasing confidence, acting as a second opinion, reducing information search time, and enabling delegation of decisions to nurses and technicians. However, the prediction tool did not lead to changes in clinical action and was found less useful in cases where the quality of data was poor or when VT/VF predictions were found to be irrelevant for evaluating the patient.
When transitioning from AI development to testing its feasibility for clinical implementation, we need to consider the following: expectations must be aligned with the intended use of AI; trust in the prediction tool is likely to emerge from real-world use; and AI accuracy is relational and dependent on available information and local workflows. Addressing the sociotechnical gap between the development and implementation of clinical decision-support tools based on ML in cardiac care is essential for succeeding with adoption. It is suggested to include clinical end-users, clinical contexts, and workflows throughout the overall iterative approach to design, development, and implementation.
人工智能(AI),如机器学习(ML),通过超越基于统计的模型,在改善心脏病临床决策方面显示出巨大潜力。然而,由于从算法开发到实际应用过程中的社会技术挑战,很少有基于AI的工具在心脏病诊所中得到应用。
本研究探讨了一种基于ML的预测室性心动过速和心室颤动(VT/VF)的工具如何在植入式心脏复律除颤器(ICD)患者的远程监测中支持临床决策。
七名经验丰富的电生理学家参与了一项近乎实时的可行性和定性研究,其中包括对5例盲法回顾性患者病例的演练、预测工具的使用以及问卷调查和访谈问题。所有环节均进行了视频录制,评估预测工具的环节逐字转录。数据通过基于扎根理论的归纳定性方法进行分析。
发现该预测工具在ICD远程监测中支持决策具有潜力,可提供安心感、增强信心、提供第二意见、减少信息搜索时间,并使护士和技术人员能够进行决策委托。然而,该预测工具并未导致临床行动的改变,并且在数据质量较差或VT/VF预测与评估患者无关的情况下,发现其用处较小。
从AI开发过渡到测试其临床应用可行性时,我们需要考虑以下几点:期望必须与AI的预期用途一致;对预测工具的信任可能源于实际使用;AI准确性是相关的,并且取决于可用信息和当地工作流程。解决基于ML的临床决策支持工具在心脏护理开发与应用之间的社会技术差距对于成功采用至关重要。建议在设计、开发和实施的整个迭代方法中纳入临床最终用户、临床环境和工作流程。